---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-058331"
form_type: "8-K"
ticker: "KTTA"
cik: "0001841330"
company_name: "Pasithea Therapeutics Corp."
filed_at: "2023-07-20T23:59:59+00:00"
generated_at: "2026-06-13T05:46:28.433089+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Pasithea announces $4M tender offer for common stock at $0.70/share, expected Q3 2023

## Summary
- Board authorized $4.0M tender offer to repurchase up to ~5.7M shares at $0.70 per share in cash.
- Tender offer expected to close in the third quarter of 2023.
- Executive officers and directors will not tender any shares in the offer.
- If oversubscribed, shares will be accepted on a pro rata basis.

## SEC filing metadata
- accession: 0001213900-23-058331
- form_type: 8-K
- ticker: KTTA
- cik: 0001841330
- company_name: Pasithea Therapeutics Corp.
- filed_at: 2023-07-20T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1841330/000121390023058331/0001213900-23-058331-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1841330/000121390023058331/ea182059-8k_pasithea.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-058331
- JSON: https://secwatch.observer/filing/0001213900-23-058331.json
- Plain text: https://secwatch.observer/filing/0001213900-23-058331.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.